77 related articles for article (PubMed ID: 11640895)
1. The FLT3 tyrosine kinase receptor inhibits neural stem/progenitor cell proliferation and collaborates with NGF to promote neuronal survival.
Brazel CY; Ducceschi MH; Pytowski B; Levison SW
Mol Cell Neurosci; 2001 Oct; 18(4):381-93. PubMed ID: 11640895
[TBL] [Abstract][Full Text] [Related]
2. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
[TBL] [Abstract][Full Text] [Related]
3. flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors.
Hunte BE; Hudak S; Campbell D; Xu Y; Rennick D
J Immunol; 1996 Jan; 156(2):489-96. PubMed ID: 8543798
[TBL] [Abstract][Full Text] [Related]
4. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.
Piacibello W; Garetto L; Sanavio F; Severino A; Fubini L; Stacchini A; Dragonetti G; Aglietta M
Exp Hematol; 1996 Feb; 24(2):340-6. PubMed ID: 8641363
[TBL] [Abstract][Full Text] [Related]
5. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.
Eder M; Hemmati P; Kalina U; Ottman OG; Hoelzer D; Lyman SD; Ganser A
Exp Hematol; 1996 Feb; 24(2):371-7. PubMed ID: 8641368
[TBL] [Abstract][Full Text] [Related]
6. Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells.
Hjertson M; Sundström C; Lyman SD; Nilsson K; Nilsson G
Exp Hematol; 1996 May; 24(6):748-54. PubMed ID: 8635531
[TBL] [Abstract][Full Text] [Related]
7. Modulation of haematopoietic progenitor development by FLT-3 ligand.
Banu N; Deng B; Lyman SD; Avraham H
Cytokine; 1999 Sep; 11(9):679-88. PubMed ID: 10479404
[TBL] [Abstract][Full Text] [Related]
8. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.
Ogawa M; Sugawara S; Kunisada T; Sudo T; Hayashi S; Nishikawa S; Kodama H; Nishikawa S
Exp Hematol; 1998 Jun; 26(6):478-88. PubMed ID: 9620281
[TBL] [Abstract][Full Text] [Related]
9. Fms-related tyrosine kinase 3 expression discriminates hematopoietic stem cells subpopulations with differing engraftment-potential: identifying the most potent combination.
Huang Y; Ratajczak MZ; Reca R; Xu H; Tanner M; Rezzoug F; Hussain LR; Fugier-Vivier I; Bolli R; Ildstad ST
Transplantation; 2008 Apr; 85(8):1175-84. PubMed ID: 18431239
[TBL] [Abstract][Full Text] [Related]
10. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
Rossner MT; McArthur GA; Allen JD; Metcalf D
Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
[TBL] [Abstract][Full Text] [Related]
12. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
Lyman SD; Brasel K; Rousseau AM; Williams DE
Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
[TBL] [Abstract][Full Text] [Related]
13. Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations.
Robinson LJ; Xue J; Corey SJ
Exp Hematol; 2005 Apr; 33(4):469-79. PubMed ID: 15781338
[TBL] [Abstract][Full Text] [Related]
14. Normal and oncogenic FLT3.
Naoe T; Kiyoi H
Cell Mol Life Sci; 2004 Dec; 61(23):2932-8. PubMed ID: 15583855
[TBL] [Abstract][Full Text] [Related]
15. Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7.
Ray RJ; Paige CJ; Furlonger C; Lyman SD; Rottapel R
Eur J Immunol; 1996 Jul; 26(7):1504-10. PubMed ID: 8766553
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase.
Casteran N; Rottapel R; Beslu N; Lecocq E; Birnbaum D; Dubreuil P
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):443-56. PubMed ID: 7920189
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
[TBL] [Abstract][Full Text] [Related]
18. Distinct actions of Flt3 ligand and stem cell factor on myeloid lineage selection and maturation of granulocytes versus macrophages.
Dannaeus K; Nilsson K; Jönsson JI
Exp Hematol; 1998 Apr; 26(4):345-52. PubMed ID: 9546318
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophin channeling of neural progenitor cell differentiation.
Benoit BO; Savarese T; Joly M; Engstrom CM; Pang L; Reilly J; Recht LD; Ross AH; Quesenberry PJ
J Neurobiol; 2001 Mar; 46(4):265-80. PubMed ID: 11180154
[TBL] [Abstract][Full Text] [Related]
20. Neurogenesis in postnatal mouse dorsal root ganglia.
Namaka MP; Sawchuk M; MacDonald SC; Jordan LM; Hochman S
Exp Neurol; 2001 Nov; 172(1):60-9. PubMed ID: 11681840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
